Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 59.46% vs 10.86% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -23.28% vs 50.99% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -47.87% vs 156.25% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Suzhou Highfine Biotech Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 21.69% vs -0.07% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 59.46% vs 10.86% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -43.07% vs 18.10% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -23.28% vs 50.99% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -58.70% vs 15.97% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -47.87% vs 156.25% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






